1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Gastric Cancer Diagnostic Proceadure Market – By Healthcare Providers

1.3.2        Gastric Cancer Diagnostic Procedure Market – By Symptom Types

1.3.3        Gastric Cancer Diagnostic Procedure Market – By Body Fluid

1.3.4        Gastric Cancer Diagnostic Procedure Market – By Procedures

1.3.5        Gastric Cancer Diagnostic Procedure Market – By Offerings

1.3.6        Gastric Cancer Diagnostic Procedure Market – By Disease Indication

1.3.7        Gastric Cancer Diagnostic Procedure Market – By Country

2.           Gastric Cancer Diagnostic Procedure Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Gastric Cancer Diagnostic Procedure Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        US – PEST Analysis

4.3         Expert Opinion

4.4         Gastric Cancer Prevalence Statistics

4.5         Pre-Diagnosis Workflow

4.6         Post-Diagnosis Workflow

5.           United States Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Gastrointestinal (GI) Diseases

5.1.2        Growing Geriatric Population in US

5.2         Market Restraints

5.2.1        Shortage of Medical Laboratory Professionals

5.3         Market Opportunities

5.3.1        Rising Awareness on Gastric Cancer

5.4         Future Trends

5.4.1        Development of AI-Based Gastric Cancer Diagnostic Platform

5.5         Impact Analysis

6.           Gastric Cancer Diagnostic Procedure Market – US Analysis

6.1         United States Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis

6.2         Market Positioning of Key Players

7.           United States Gastric Cancer Diagnostic Procedure Market Analysis – by Healthcare Providers

7.1         Overview

7.2         Diagnostic Laboratories

7.2.1        Overview

7.2.2        Diagnostic Laboratories: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

7.2.2.1          United States Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, by Type, 2019–2028 (US$ Million)

7.3         Hospitals

7.3.1        Overview

7.3.2        Hospitals: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          United States Gastric Cancer Diagnostic Procedure Market, by Hospitals, by Type, 2019–2028 (US$ Million)

7.4         Cancer Research Institutes

7.4.1        Overview

7.4.2        Cancer Research Institutes: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1          United States Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, by Type, 2019–2028 (US$ Million)

7.5         Oncology Specialty Clinics

7.5.1        Overview

7.5.2        Oncology Specialty Clinics: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1          United States Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Clinics, by Type, 2019–2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1          United States Gastric Cancer Diagnostic Procedure Market, by Others, by Type, 2019–2028 (US$ Million)

8.           United States Gastric Cancer Diagnostic Procedure Market Analysis – by Symptom Type

8.1         Overview

8.2         Symptomatic

8.2.1        Overview

8.2.2        Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

8.3         Asymptomatic

8.3.1        Overview

8.3.2        Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

9.           United States Gastric Cancer Diagnostic Procedure Market Analysis – by Body Fluid

9.1         Overview

9.2         Blood

9.2.1        Overview

9.2.2        Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

9.3         Urine

9.3.1        Overview

9.3.2        Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Saliva

9.4.1        Overview

9.4.2        Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

9.5         Stomach Wash/Gastric Juice

9.5.1        Overview

9.5.2        Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

9.6         Tissue

9.6.1        Overview

9.6.2        Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

9.7         Other

9.7.1        Overview

9.7.2        Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

10.        United States Gastric Cancer Diagnostic Procedure Market Analysis – by Procedures

10.1      Overview

10.2      Endoscopic Procedure

10.2.1     Overview

10.2.2     Endoscopic Procedure: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

10.2.2.1       United States Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, by Type, 2019–2028 (US$ Million)

10.3      Biopsy and Tissue Tests

10.3.1     Overview

10.3.2     Biopsy and Tissue Tests: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Lab Tests

10.4.1     Overview

10.4.2     Lab Tests: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

10.4.2.1       United States Gastric Cancer Diagnostic Procedure Market, by Lab Tests, by Type, 2019–2028 (US$ Million)

10.5      In-Vitro Diagnostic Tests

10.5.1     Overview

10.5.2     In-Vitro Diagnostic Tests: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

10.5.2.1       United States Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostic Tests, by Type, 2019–2028 (US$ Million)

10.6      Imaging Tests

10.6.1     Overview

10.6.2     Imaging Tests: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

10.6.2.1       United States Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, by Type, 2019–2028 (US$ Million)

10.7      Molecular Diagnostics

10.7.1     Overview

10.7.2     Molecular Diagnostics: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

10.7.2.1       United States Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostic, by Type, 2019–2028 (US$ Million)

10.8      Multiplexing Molecular Diagnostics and Immunoassay

10.8.1     Overview

10.8.2     Multiplexing Molecular Diagnostics and Immunoassay: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

10.9      Others

10.9.1     Overview

10.9.2     Others: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

11.        United States Gastric Cancer Diagnostic Procedure Market Analysis – by Offerings

11.1      Overview

11.2      Instruments

11.2.1     Overview

11.2.2     Instruments: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

11.3      Reagents and Consumables

11.3.1     Overview

11.3.2     Reagents and Consumables: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

11.4      Services

11.4.1     Overview

11.4.2     Services: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

12.        United States Gastric Cancer Diagnostic Procedure Market Analysis – by Disease Indication

12.1      Overview

12.2      Early Gastric Cancer

12.2.1     Overview

12.2.2     Early Gastric Cancer: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

12.3      Gastric Cancer Advanced Types

12.3.1     Overview

12.3.2     Gastric Cancer Advanced Types: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

13.        United States Gastric Cancer Diagnostic Procedure Market: Impact Assessment of COVID-19 Pandemic

13.1      US: Impact Assessment of COVID-19 Pandemic

14.        United States Gastric Cancer Diagnostic Procedure Market – Industry Landscape

14.1      Overview

14.2      Growth Strategies in United States Gastric Cancer Diagnostic Procedure Market (%)

14.3      Organic Developments

14.3.1     Overview

14.4      Inorganic Developments

14.4.1     Overview

15.        Company Profiles

15.1      Atlas-Link Biotech Co Ltd

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      Bio-Rad Laboratories Inc

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      MiRXES Pte Ltd

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      Agilent Technologies Inc

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      F. Hoffmann-La Roche Ltd

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      bioMerieux SA

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      Thermo Fisher Scientific Inc

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      Illumina Inc

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9      Vela Diagnostics Holding Pte Ltd

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Products and Services

15.9.4     Financial Overview

15.9.5     SWOT Analysis

15.9.6     Key Developments

15.10   Myraid Genetics Inc

15.10.1  Key Facts

15.10.2  Business Description

15.10.3  Products and Services

15.10.4  Financial Overview

15.10.5  SWOT Analysis

15.10.6  Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms 

LIST OF TABLES

Table 1.             United States Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             United States Gastric Cancer Diagnostic Procedure Market, by Hospitals, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             United States Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             United States Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Clinics, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             United States Gastric Cancer Diagnostic Procedure Market, by Others, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             United States Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             United States Gastric Cancer Diagnostic Procedure Market, by Lab Tests, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             United States Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostic Tests, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             United States Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          United States Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostic, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments in the United States Gastric Cancer Diagnostic Procedure Market

Table 12.          Inorganic Developments in the United States Gastric Cancer Diagnostic Procedure Market

Table 13.          Glossary of Terms 

LIST OF FIGURES

Figure 1.           Gastric Cancer Diagnostic Procedure Market Segmentation

Figure 2.           United States Gastric Cancer Diagnostic Procedure Market Overview

Figure 3.           Asymptomatic Held Largest Share of Gastric Cancer Diagnostic Procedure Market

Figure 4.           United States Gastric Cancer Diagnostic Procedure Market, Industry Landscape

Figure 5.           US PEST Analysis

Figure 6.           Expert Opinion

Figure 7.           Gastric Cancer Diagnostic Procedure Market Impact Analysis of Drivers and Restraints

Figure 8.           United States Gastric Cancer Diagnostic Procedure Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Market Positioning of Key Players in United States Gastric Cancer Diagnostic Procedure Market

Figure 10.        United States Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2021 & 2028 (%)

Figure 11.        Diagnostic Laboratories: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Hospitals: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Cancer Research Institutes: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Oncology Specialty Clinics: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        United States Gastric Cancer Diagnostic Procedure Market, by Symptom Type, 2021 & 2028 (%)

Figure 17.        Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        United States Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2021 & 2028 (%)

Figure 20.        Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.        United States Gastric Cancer Diagnostic Procedure Market, by Procedures, 2021 & 2028 (%)

Figure 27.        Endoscopic Procedure: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Biopsy and Tissue Tests: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Lab Tests: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        In-Vitro Diagnostic Tests: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Imaging Tests: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Molecular Diagnostics: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Multiplexing Molecular Diagnostics and Immunoassay: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Others: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        United States Gastric Cancer Diagnostic Procedure Market, by Offerings, 2021 & 2028 (%)

Figure 36.        Instruments: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Reagents and Consumables: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Services: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        United States Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2021 & 2028 (%)

Figure 40.        Early Gastric Cancer: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Gastric Cancer Advanced Types: United States Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Impact of COVID-19 Pandemic on US Gastric Cancer Diagnostic Procedure Market

Figure 43.        Growth Strategies in United States Gastric Cancer Diagnostic Procedure Market (%)